Breakdown | |||||
TTM | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|---|
Income Statement | Total Revenue | ||||
539.96B | 523.72B | 516.95B | 486.58B | 432.57B | 465.95B | Gross Profit |
93.36B | 88.61B | 76.93B | 91.35B | 90.07B | 93.61B | EBIT |
21.00B | 18.19B | 7.54B | 22.20B | 24.19B | 24.61B | EBITDA |
40.26B | 38.83B | 32.45B | 47.01B | 28.46B | 32.82B | Net Income Common Stockholders |
13.05B | 9.04B | 7.20B | 16.76B | 3.37B | 7.48B |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | ||||
37.44B | 35.21B | 31.30B | 45.19B | 61.23B | 36.35B | Total Assets |
560.90B | 543.19B | 526.20B | 532.60B | 506.95B | 470.00B | Total Debt |
180.48B | 161.32B | 163.57B | 155.41B | 146.23B | 132.62B | Net Debt |
143.03B | 126.23B | 132.26B | 110.22B | 85.00B | 96.27B | Total Liabilities |
314.54B | 305.10B | 305.44B | 311.69B | 299.85B | 268.81B | Stockholders Equity |
228.92B | 221.26B | 205.47B | 203.09B | 190.71B | 186.28B |
Cash Flow | Free Cash Flow | ||||
0.00 | 14.11B | -17.71B | -19.36B | 15.26B | 18.92B | Operating Cash Flow |
0.00 | 38.04B | 695.00M | 1.49B | 41.94B | 48.68B | Investing Cash Flow |
0.00 | -23.93B | -15.12B | -18.02B | -25.67B | -29.68B | Financing Cash Flow |
0.00 | -11.05B | 85.00M | -626.00M | 8.19B | -15.74B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
72 Outperform | $231.16B | 3.57 | 20.86% | 3.98% | 10.45% | 873.78% | |
69 Neutral | €96.32B | 7.38 | 5.77% | 4.66% | 3.91% | 50.98% | |
69 Neutral | $2.05T | 10.59 | 8.51% | 3.96% | 7.10% | 38.66% | |
65 Neutral | $300.03B | 8.81 | 5.00% | 4.46% | 32.71% | 24.06% | |
65 Neutral | $394.22B | 11.83 | 9.85% | 2.30% | 12.20% | ― | |
49 Neutral | $1.99B | -1.09 | -21.26% | 3.60% | 1.47% | -31.20% | |
31 Underperform | $8.55B | ― | -22.81% | ― | -1.66% | 48.75% |